Literature DB >> 28827219

Death Receptor Signaling in the Heart: Cell Survival, Apoptosis, and Necroptosis.

Dulguun Amgalan1, Yun Chen1, Richard N Kitsis2.   

Abstract

Entities:  

Keywords:  Editorials; TNF; TRAF2; apoptosis; cell death; necroptosis; necrosis

Mesh：

Substances：

Year:  2017        PMID： 28827219      PMCID： PMC5657500          DOI： 10.1161/CIRCULATIONAHA.117.029566

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

1.  Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo.

Authors:  Peiyee Lee; Masataka Sata; David J Lefer; Stephen M Factor; Kenneth Walsh; Richard N Kitsis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-10-31       Impact factor: 4.733

Review 2.  Mechanisms of cell death in heart disease.

Authors:  Klitos Konstantinidis; Russell S Whelan; Richard N Kitsis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-17       Impact factor: 8.311

3.  Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy.

Authors:  Kai-Chun Yang; Xiucui Ma; Haiyan Liu; John Murphy; Philip M Barger; Douglas L Mann; Abhinav Diwan
Journal:  Circ Heart Fail       Date:  2014-10-22       Impact factor: 8.790

4.  CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.

Authors:  Ting Zhang; Yan Zhang; Mingyao Cui; Li Jin; Yimei Wang; Fengxiang Lv; Yuli Liu; Wen Zheng; Haibao Shang; Jun Zhang; Mao Zhang; Hongkun Wu; Jiaojiao Guo; Xiuqin Zhang; Xinli Hu; Chun-Mei Cao; Rui-Ping Xiao
Journal:  Nat Med       Date:  2016-01-04       Impact factor: 53.440

5.  RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction.

Authors:  Mark Luedde; Matthias Lutz; Natalie Carter; Justyna Sosna; Christoph Jacoby; Mihael Vucur; Jérémie Gautheron; Christoph Roderburg; Nadine Borg; Florian Reisinger; Hans-Joerg Hippe; Andreas Linkermann; Monika J Wolf; Stefan Rose-John; Renate Lüllmann-Rauch; Dieter Adam; Ulrich Flögel; Mathias Heikenwalder; Tom Luedde; Norbert Frey
Journal:  Cardiovasc Res       Date:  2014-06-11       Impact factor: 10.787

6.  Cardioprotective Role of Tumor Necrosis Factor Receptor-Associated Factor 2 by Suppressing Apoptosis and Necroptosis.

Authors:  Xiaoyun Guo; Haifeng Yin; Lei Li; Yi Chen; Jing Li; Jessica Doan; Rachel Steinmetz; Qinghang Liu
Journal:  Circulation       Date:  2017-06-01       Impact factor: 29.690

7.  The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart.

Authors:  Jana S Burchfield; Jian-Wen Dong; Yasushi Sakata; Feng Gao; Huei-Ping Tzeng; Veli K Topkara; Mark L Entman; Natarajan Sivasubramanian; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2009-10-30       Impact factor: 8.790

Review 8.  Regulated necrosis: disease relevance and therapeutic opportunities.

Authors:  Marcus Conrad; José Pedro Friedmann Angeli; Peter Vandenabeele; Brent R Stockwell
Journal:  Nat Rev Drug Discov       Date:  2016-01-18       Impact factor: 84.694

9.  The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB.

Authors:  Laiqun Zhang; Ken Blackwell; Zhaohui Shi; Hasem Habelhah
Journal:  J Mol Biol       Date:  2010-01-11       Impact factor: 5.469

10.  Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization.

Authors:  Shireen A Sarraf; Malavika Raman; Virginia Guarani-Pereira; Mathew E Sowa; Edward L Huttlin; Steven P Gygi; J Wade Harper
Journal:  Nature       Date:  2013-03-17       Impact factor: 49.962
View more
  8 in total

Review 1.  Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease.

Authors:  Dominic P Del Re; Dulguun Amgalan; Andreas Linkermann; Qinghang Liu; Richard N Kitsis
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

2.  Inflammation in myocardial injury: mesenchymal stem cells as potential immunomodulators.

Authors:  Weiang Yan; Ejlal Abu-El-Rub; Sekaran Saravanan; Lorrie A Kirshenbaum; Rakesh C Arora; Sanjiv Dhingra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-24       Impact factor: 4.733

Review 3.  Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.

Authors:  Massimo Bonora; Mariusz R Wieckowski; David A Sinclair; Guido Kroemer; Paolo Pinton; Lorenzo Galluzzi
Journal:  Nat Rev Cardiol       Date:  2019-01       Impact factor: 32.419

4.  In vivo detection of programmed cell death during mouse heart development.

Authors:  Kristel Martínez-Lagunas; Yoshifumi Yamaguchi; Cora Becker; Caroline Geisen; Marco C DeRuiter; Masayuki Miura; Bernd K Fleischmann; Michael Hesse
Journal:  Cell Death Differ       Date:  2019-09-30       Impact factor: 15.828

5.  Nicorandil inhibits cardiomyocyte apoptosis and improves cardiac function by suppressing the HtrA2/XIAP/PARP signaling after coronary microembolization in rats.

Authors:  Jing Zheng; Manyun Long; Zhenbai Qin; Fen Wang; Zhiqing Chen; Lang Li
Journal:  Pharmacol Res Perspect       Date:  2021-02

Review 6.  COVID-lateral damage: cardiovascular manifestations of SARS-CoV-2 infection.

Authors:  Sadeer Al-Kindi; David A Zidar
Journal:  Transl Res       Date:  2021-11-12       Impact factor: 7.012

Review 7.  Early Protective Role of Inflammation in Cardiac Remodeling and Heart Failure: Focus on TNFα and Resident Macrophages.

Authors:  Sophie Besse; Sophie Nadaud; Elise Balse; Catherine Pavoine
Journal:  Cells       Date:  2022-04-06       Impact factor: 6.600

Review 8.  Metabolic remodeling induced by mitokines in heart failure.

Authors:  Jiahao Duan; Zijun Chen; Yeshun Wu; Bin Zhu; Ling Yang; Chun Yang
Journal:  Aging (Albany NY)       Date:  2019-09-09       Impact factor: 5.682
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.